Evidence map›Paper›PMID 34327793›Full record

ArticleInternational journal of clinical practice2021

Short-term experiences of a liver transplant centre before and after the COVID-19 pandemic.

Sibel Altunisik Toplu, Yasar Bayindir, Sezai Yilmaz, Murat Yalçınsoy, Baris Otlu, Adem Kose, Tevfik Tolga Sahin, Sami Akbulut, Burak Isik, Adil Başkiran and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sibel Altunisik TopluDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey.ORCID https://orcid.org/0000-0002-2915-4666
Yasar BayindirDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Sezai YilmazDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Murat YalçınsoyDepartment of Chest Diseases, Faculty of Medicine, Inonu University, Malatya, Turkey.
Baris OtluDepartment of Clinical Microbiology, Molecular Microbiology Section, Faculty of Medicine, Inonu University, Malatya, Turkey.
Adem KoseDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey.ORCID https://orcid.org/0000-0002-1853-1243
Tevfik Tolga SahinDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Sami AkbulutDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Burak IsikDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Adil BaşkiranDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Cemalettin KocDepartment of General Surgery, Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.
Inonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimWith the COVID-19 pandemic, managing the process of solid organ transplantation has become a significant matter for transplant centres. In this study, we report our experiences on evaluating the effects of COVID-19 in patients with recent liver transplants. MATERIALS AND

methodsWe evaluated patients who received liver transplants during three close consecutive periods of time. For transplants conducted between October 1 and December 31, 2019, January 1 and March 10, 2020 and March 11 and June 22, 2020, the lung tomographies of patients were inspected for radiological signs of viral pneumonia. For patients after March 11, 2020, the hospital's electronic database system was scanned for preoperative and postoperative SARS-CoV-2 testing from Real-time Polymerase Chain Reaction (RT-PCR) of the respiratory tract samples.

resultsA total of 149 patients over the age of 18 who received liver transplants at our centre between October 1, 2019 and June 22, 2020 were evaluated. During this time span, our centre conducted liver transplants on patients from 34 different provinces and also abroad. Within this time period, a total of nine patients had respiratory samples with a positive SARS-CoV-2 RT-PCR test. PCR of respiratory tract samples was performed in 21 (14%) patients to identify the other potential infective agents in the respiratory tracts; Rhinovirus and Influenza A were detected in two and respiratory syncytial virus (RSV) was detected in one patient. During the transplant periods, 99 (67.1%) patients were evaluated with computed tomography (CT). The CT findings of 18 (12%) patients were consistent with viral pneumonia. There was a statistically significant difference between the groups only in terms of air bronchogram findings (P = .012).

conclusionThe clinical status of our short-term liver transplant patients was far better than we originally anticipated, but it remains obvious that the necessary precautions should continue to be taken.

Indexed as

COVID-19Liver TransplantationAdultCOVID-19 TestingHumansMiddle AgedPandemicsSARS-CoV-2

Identifiers

PMID34327793
PMCPMC8420587
OpenAlexW3184126272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.